Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360º synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing geriatric population
3.2.1.2 Increasing research & development activities and funding for osteoarthritis therapeutics
3.2.1.3 High prevalence of osteoarthritis
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with drugs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Drug Type, 2018 – 2032 ($ Million)
5.1 Key trends
5.2 Viscosupplementation agents
5.3 Nonsteroidal anti-inflammatory drugs
5.3.1 Naproxen
5.3.2 Aspirin
5.3.3 Diclofenac
5.3.4 Ibuprofen
5.3.5 Celecoxib
5.3.6 Meloxicam
5.3.7 Piroxicam
5.3.8 Ketoprofen
5.3.9 Other NSAIDs
5.4 Analgesics
5.4.1 Duloxetine
5.4.2 Acetaminophen
5.5 Corticosteroids
5.6 Other drug types
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2018 – 2032 ($ Million)
6.1 Key trends
6.2 Oral
6.3 Parenteral
6.4 Topical
Chapter 7 Market Estimates and Forecast, By Anatomy, 2018 – 2032 ($ Million)
7.1 Key trends
7.2 Ankle osteoarthritis
7.3 Hip osteoarthritis
7.4 Knee osteoarthritis
7.5 Shoulder osteoarthritis
7.6 Other anatomies
Chapter 8 Market Estimates and Forecast, By Medication, 2018 – 2032 ($ Million)
8.1 Key trends
8.2 Prescription drugs
8.3 Over-the-counter drugs
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Million)
9.1 Key trends
9.2 Hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacy
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Anika Therapeutics
11.2 Assertio Holdings, Inc.
11.3 Bayer AG
11.4 Bioventus
11.5 Ferring Pharmaceuticals Inc.
11.6 GSK plc
11.7 Novartis AG
11.8 Pacira Pharmaceuticals, Inc
11.9 Pfizer Inc
11.10 Sanofi SA
11.11 Zimmer Biomet Holdings, Inc.
